My watch list
my.chemeurope.com  

my.chemeurope.com

With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

Meglumine antimoniate



Meglumine antimoniate
Systematic (IUPAC) name
 ?
Identifiers
CAS number 133-51-7
ATC code P01CB01
PubChem 64953
Chemical data
Formula Variable
Mol. mass Variable
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

v • d • e
Antiprotozoals: Agents against leishmaniasis and trypanosomiasis (P01C)
Nitroimidazole derivativesBenznidazole
Antimony compoundsPentavalent antimonials (Meglumine antimoniate, Sodium stibogluconate)
Nitrofuran derivativesNifurtimox
Arsenic compoundsMelarsoprol
Other agentsPentamidine - Suramin - Eflornithine
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Meglumine_antimoniate". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE